Raw JSON Patch
[
{
"op": "replace",
"path": "/protocolSection/identificationModule/orgStudyIdInfo/id",
"value": "2010-056(b)"
},
{
"op": "replace",
"path": "/protocolSection/statusModule/statusVerifiedDate",
"value": "2023-04"
},
{
"op": "replace",
"path": "/protocolSection/statusModule/overallStatus",
"value": "TERMINATED"
},
{
"op": "replace",
"path": "/protocolSection/statusModule/completionDateStruct/date",
"value": "2017-07-26"
},
{
"op": "replace",
"path": "/protocolSection/statusModule/completionDateStruct/type",
"value": "ACTUAL"
},
{
"op": "replace",
"path": "/protocolSection/statusModule/lastUpdateSubmitDate",
"value": "2023-04-05"
},
{
"op": "replace",
"path": "/protocolSection/statusModule/lastUpdatePostDateStruct/date",
"value": "2023-04-27"
},
{
"op": "add",
"path": "/protocolSection/statusModule/whyStopped",
"value": "Primary co-investigator leaving the institution & funding transfer."
},
{
"op": "add",
"path": "/protocolSection/statusModule/resultsFirstSubmitDate",
"value": "2020-12-21"
},
{
"op": "add",
"path": "/protocolSection/statusModule/resultsFirstSubmitQcDate",
"value": "2023-04-05"
},
{
"op": "add",
"path": "/protocolSection/statusModule/resultsFirstPostDateStruct",
"value": {
"date": "2023-04-27",
"type": "ACTUAL"
}
},
{
"op": "replace",
"path": "/protocolSection/sponsorCollaboratorsModule/responsibleParty/investigatorFullName",
"value": "Abhinav Deol"
},
{
"op": "replace",
"path": "/protocolSection/sponsorCollaboratorsModule/responsibleParty/investigatorTitle",
"value": "Investigator"
},
{
"op": "replace",
"path": "/protocolSection/outcomesModule/primaryOutcomes/0/measure",
"value": "Progression-free Survival"
},
{
"op": "replace",
"path": "/protocolSection/outcomesModule/primaryOutcomes/0/timeFrame",
"value": "From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 7 years.."
},
{
"op": "add",
"path": "/protocolSection/outcomesModule/primaryOutcomes/0/description",
"value": "Progression is defined using Response Evaluation Criteria In Solid Tumors Criteria (RECIST v1.0), as a 20% increase in the sum of the longest diameter of target lesions, or a measurable increase in a non-target lesion, or the appearance of new lesion"
},
{
"op": "remove",
"path": "/protocolSection/outcomesModule/primaryOutcomes/1"
},
{
"op": "replace",
"path": "/protocolSection/outcomesModule/secondaryOutcomes/0/measure",
"value": "Overall Deaths"
},
{
"op": "replace",
"path": "/protocolSection/outcomesModule/secondaryOutcomes/0/timeFrame",
"value": "From date of randomization until date of death from any cause or end of study, whichever came first, assessed up to 7 years"
},
{
"op": "add",
"path": "/protocolSection/outcomesModule/secondaryOutcomes/0/description",
"value": "Total number of deaths"
},
{
"op": "remove",
"path": "/annotationSection"
},
{
"op": "replace",
"path": "/hasResults",
"value": true
},
{
"op": "add",
"path": "/resultsSection",
"value": {
"moreInfoModule": {
"pointOfContact": {
"email": "aweise3@hfhs.org",
"phone": "248-344-6688",
"title": "Dr. Amy Weise",
"organization": "Barbara Ann Karmanos Cancer Institute"
},
"certainAgreement": {
"piSponsorEmployee": true
}
},
"adverseEventsModule": {
"timeFrame": "Up to 7 years.",
"eventGroups": [
{
"id": "EG000",
"title": "Treated",
"description": "All 8 participants enrolled",
"otherNumAtRisk": 8,
"deathsNumAtRisk": 8,
"otherNumAffected": 8,
"seriousNumAtRisk": 8,
"deathsNumAffected": 1,
"seriousNumAffected": 0
}
],
"otherEvents": [
{
"term": "Hypertension",
"notes": "Grade 2",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 1,
"numEvents": 1,
"numAffected": 1
}
],
"organSystem": "Cardiac disorders",
"assessmentType": "SYSTEMATIC_ASSESSMENT",
"sourceVocabulary": "CTCAE (3.0)"
},
{
"term": "chills/rigors",
"notes": "grade 1 1 grade 2 5 grade 31",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 8,
"numEvents": 7,
"numAffected": 7
}
],
"organSystem": "General disorders",
"assessmentType": "SYSTEMATIC_ASSESSMENT",
"sourceVocabulary": "CTCAE (3.0)"
},
{
"term": "Nausea",
"notes": "Grade 1 5 Grade 2 1",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 8,
"numEvents": 7,
"numAffected": 7
}
],
"organSystem": "Gastrointestinal disorders",
"assessmentType": "SYSTEMATIC_ASSESSMENT",
"sourceVocabulary": "CTCAE (3.0)"
},
{
"term": "Vomiting",
"notes": "Grade 1 3 Grade 2 1",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 8,
"numEvents": 4,
"numAffected": 4
}
],
"organSystem": "Gastrointestinal disorders",
"assessmentType": "SYSTEMATIC_ASSESSMENT",
"sourceVocabulary": "CTCAE (3.0)"
},
{
"term": "fatigue",
"notes": "Grade 1 4 Grade 2 3",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 8,
"numEvents": 7,
"numAffected": 7
}
],
"organSystem": "General disorders",
"assessmentType": "SYSTEMATIC_ASSESSMENT",
"sourceVocabulary": "CTCAE (3.0)"
},
{
"term": "Rash",
"notes": "Grade 1 3",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 8,
"numEvents": 3,
"numAffected": 3
}
],
"organSystem": "General disorders",
"assessmentType": "SYSTEMATIC_ASSESSMENT",
"sourceVocabulary": "CTCAE (3.0)"
},
{
"term": "edema",
"notes": "Grade 1 1 Grade 2 1",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 8,
"numEvents": 2,
"numAffected": 2
}
],
"organSystem": "General disorders",
"assessmentType": "SYSTEMATIC_ASSESSMENT",
"sourceVocabulary": "CTCAE (3.0)"
},
{
"term": "neuroppathy",
"notes": "Grade 1 1 Grade 2 1 Grade 3 1",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 8,
"numEvents": 3,
"numAffected": 3
}
],
"organSystem": "Nervous system disorders",
"assessmentType": "SYSTEMATIC_ASSESSMENT",
"sourceVocabulary": "CTCAE (3.0)"
},
{
"term": "hypotension",
"notes": "Grade 2 5",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 8,
"numEvents": 5,
"numAffected": 5
}
],
"organSystem": "General disorders",
"assessmentType": "SYSTEMATIC_ASSESSMENT",
"sourceVocabulary": "CTCAE (3.0)"
},
{
"term": "fever",
"notes": "grade 1 4 Grade 2 2",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 8,
"numEvents": 6,
"numAffected": 6
}
],
"organSystem": "General disorders",
"assessmentType": "SYSTEMATIC_ASSESSMENT",
"sourceVocabulary": "CTCAE (3.0)"
},
{
"term": "hyponatremia",
"notes": "Grade 1 1",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 8,
"numEvents": 1,
"numAffected": 1
}
],
"organSystem": "General disorders",
"assessmentType": "SYSTEMATIC_ASSESSMENT",
"sourceVocabulary": "CTCAE (3.0)"
},
{
"term": "hypoglycemia",
"notes": "Grade 1 2",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 8,
"numEvents": 2,
"numAffected": 2
}
],
"organSystem": "Endocrine disorders",
"assessmentType": "SYSTEMATIC_ASSESSMENT",
"sourceVocabulary": "CTCAE (3.0)"
},
{
"term": "neutropenia",
"notes": "Grade 1 1 Grade 2 1 Grade 3 1 Grade 4 1",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 8,
"numEvents": 4,
"numAffected": 4
}
],
"organSystem": "General disorders",
"assessmentType": "SYSTEMATIC_ASSESSMENT",
"sourceVocabulary": "CTCAE (3.0)"
},
{
"term": "AST elevation",
"notes": "grade 1 1",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 8,
"numEvents": 1,
"numAffected": 1
}
],
"organSystem": "General disorders",
"assessmentType": "SYSTEMATIC_ASSESSMENT",
"sourceVocabulary": "CTCAE (3.0)"
},
{
"term": "ALT elevation",
"notes": "Grade 1 1",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 8,
"numEvents": 1,
"numAffected": 1
}
],
"organSystem": "General disorders",
"assessmentType": "SYSTEMATIC_ASSESSMENT",
"sourceVocabulary": "CTCAE (3.0)"
},
{
"term": "Anemia",
"notes": "Grade 1 4 Grade 2 1",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 8,
"numEvents": 5,
"numAffected": 5
}
],
"organSystem": "Blood and lymphatic system disorders",
"assessmentType": "SYSTEMATIC_ASSESSMENT",
"sourceVocabulary": "CTCAE (3.0)"
},
{
"term": "Afibrillation",
"notes": "Grade 2 1",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 8,
"numEvents": 1,
"numAffected": 1
}
],
"organSystem": "Cardiac disorders",
"assessmentType": "SYSTEMATIC_ASSESSMENT",
"sourceVocabulary": "CTCAE (3.0)"
},
{
"term": "Diarrhea",
"notes": "Grade 1 1",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 8,
"numEvents": 1,
"numAffected": 1
}
],
"organSystem": "Gastrointestinal disorders",
"assessmentType": "SYSTEMATIC_ASSESSMENT",
"sourceVocabulary": "CTCAE (3.0)"
},
{
"term": "Infection",
"notes": "Grade 1 2 Grade 2 1",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 8,
"numEvents": 3,
"numAffected": 3
}
],
"organSystem": "Infections and infestations",
"assessmentType": "SYSTEMATIC_ASSESSMENT",
"sourceVocabulary": "CTCAE (3.0)"
},
{
"term": "Low platelets",
"notes": "Grade 1 3 Grade 2 2",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 8,
"numEvents": 5,
"numAffected": 5
}
],
"organSystem": "Blood and lymphatic system disorders",
"assessmentType": "SYSTEMATIC_ASSESSMENT",
"sourceVocabulary": "CTCAE (3.0)"
},
{
"term": "hypoalbuminemia",
"notes": "Grade 1 1 Grade 2 1",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 8,
"numEvents": 2,
"numAffected": 2
}
],
"organSystem": "Blood and lymphatic system disorders",
"assessmentType": "SYSTEMATIC_ASSESSMENT",
"sourceVocabulary": "CTCAE (3.0)"
},
{
"term": "Alkaline Phosphatase",
"notes": "Grade 1 1 Grade 2 1",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 8,
"numEvents": 2,
"numAffected": 2
}
],
"organSystem": "Blood and lymphatic system disorders",
"assessmentType": "SYSTEMATIC_ASSESSMENT",
"sourceVocabulary": "CTCAE (3.0)"
},
{
"term": "Hypercalcemia",
"notes": "Grade 1 2 Grade 2 1",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 8,
"numEvents": 2,
"numAffected": 2
}
],
"organSystem": "Blood and lymphatic system disorders",
"assessmentType": "SYSTEMATIC_ASSESSMENT",
"sourceVocabulary": "CTCAE (3.0)"
},
{
"term": "Hypocalcemia",
"notes": "Grade 3 1",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 1,
"numEvents": 1,
"numAffected": 1
}
],
"organSystem": "Blood and lymphatic system disorders",
"assessmentType": "SYSTEMATIC_ASSESSMENT",
"sourceVocabulary": "CTCAE (3.0)"
},
{
"term": "hypokalemia",
"notes": "Grade 1 1",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 8,
"numEvents": 1,
"numAffected": 1
}
],
"organSystem": "Blood and lymphatic system disorders",
"assessmentType": "SYSTEMATIC_ASSESSMENT",
"sourceVocabulary": "CTCAE (3.0)"
}
],
"frequencyThreshold": "0"
},
"outcomeMeasuresModule": {
"outcomeMeasures": [
{
"type": "PRIMARY",
"title": "Progression-free Survival",
"denoms": [
{
"units": "Participants",
"counts": [
{
"value": "8",
"groupId": "OG000"
}
]
}
],
"groups": [
{
"id": "OG000",
"title": "Activated T Cells",
"description": "All participants enrolled"
}
],
"classes": [
{
"categories": [
{
"measurements": [
{
"value": "43",
"comment": "The sample size is very small and there are too few events to estimate the upper 95% CI.",
"groupId": "OG000",
"lowerLimit": "2",
"upperLimit": "NA"
}
]
}
]
}
],
"paramType": "MEDIAN",
"timeFrame": "From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 7 years..",
"description": "Progression is defined using Response Evaluation Criteria In Solid Tumors Criteria (RECIST v1.0), as a 20% increase in the sum of the longest diameter of target lesions, or a measurable increase in a non-target lesion, or the appearance of new lesion",
"unitOfMeasure": "months",
"dispersionType": "95% Confidence Interval",
"reportingStatus": "POSTED",
"populationDescription": "Women with stage II-III, HER2/neu (0-2+) negative breast cancer treated with anti-CD3 x anti-HER2neu (Her2BI) armed, activated T cells after neoadjuvant chemotherapy"
},
{
"type": "SECONDARY",
"title": "Overall Deaths",
"denoms": [
{
"units": "Participants",
"counts": [
{
"value": "8",
"groupId": "OG000"
}
]
}
],
"groups": [
{
"id": "OG000",
"title": "Treated",
"description": "Single group study"
}
],
"classes": [
{
"categories": [
{
"measurements": [
{
"value": "1",
"groupId": "OG000"
}
]
}
]
}
],
"paramType": "COUNT_OF_PARTICIPANTS",
"timeFrame": "From date of randomization until date of death from any cause or end of study, whichever came first, assessed up to 7 years",
"description": "Total number of deaths",
"unitOfMeasure": "Participants",
"reportingStatus": "POSTED",
"populationDescription": "The participant who died had the longest follow-up time."
}
]
},
"participantFlowModule": {
"groups": [
{
"id": "FG000",
"title": "Treated",
"description": "Single group study"
}
],
"periods": [
{
"title": "Overall Study",
"milestones": [
{
"type": "STARTED",
"achievements": [
{
"groupId": "FG000",
"numSubjects": "8"
}
]
},
{
"type": "COMPLETED",
"achievements": [
{
"groupId": "FG000",
"numSubjects": "8"
}
]
},
{
"type": "NOT COMPLETED",
"achievements": [
{
"groupId": "FG000",
"numSubjects": "0"
}
]
}
]
}
]
},
"baselineCharacteristicsModule": {
"denoms": [
{
"units": "Participants",
"counts": [
{
"value": "8",
"groupId": "BG000"
}
]
}
],
"groups": [
{
"id": "BG000",
"title": "Treated",
"description": "Single group study"
}
],
"measures": [
{
"title": "Age, Continuous",
"classes": [
{
"categories": [
{
"measurements": [
{
"value": "44.5",
"groupId": "BG000",
"lowerLimit": "39",
"upperLimit": "52"
}
]
}
]
}
],
"paramType": "MEDIAN",
"unitOfMeasure": "years",
"dispersionType": "INTER_QUARTILE_RANGE"
},
{
"title": "Sex: Female, Male",
"classes": [
{
"categories": [
{
"title": "Female",
"measurements": [
{
"value": "8",
"groupId": "BG000"
}
]
},
{
"title": "Male",
"measurements": [
{
"value": "0",
"groupId": "BG000"
}
]
}
]
}
],
"paramType": "COUNT_OF_PARTICIPANTS",
"unitOfMeasure": "Participants"
},
{
"title": "Ethnicity (NIH/OMB)",
"classes": [
{
"categories": [
{
"title": "Hispanic or Latino",
"measurements": [
{
"value": "0",
"groupId": "BG000"
}
]
},
{
"title": "Not Hispanic or Latino",
"measurements": [
{
"value": "8",
"groupId": "BG000"
}
]
},
{
"title": "Unknown or Not Reported",
"measurements": [
{
"value": "0",
"groupId": "BG000"
}
]
}
]
}
],
"paramType": "COUNT_OF_PARTICIPANTS",
"unitOfMeasure": "Participants"
},
{
"title": "Race (NIH/OMB)",
"classes": [
{
"categories": [
{
"title": "American Indian or Alaska Native",
"measurements": [
{
"value": "0",
"groupId": "BG000"
}
]
},
{
"title": "Asian",
"measurements": [
{
"value": "0",
"groupId": "BG000"
}
]
},
{
"title": "Native Hawaiian or Other Pacific Islander",
"measurements": [
{
"value": "0",
"groupId": "BG000"
}
]
},
{
"title": "Black or African American",
"measurements": [
{
"value": "4",
"groupId": "BG000"
}
]
},
{
"title": "White",
"measurements": [
{
"value": "4",
"groupId": "BG000"
}
]
},
{
"title": "More than one race",
"measurements": [
{
"value": "0",
"groupId": "BG000"
}
]
},
{
"title": "Unknown or Not Reported",
"measurements": [
{
"value": "0",
"groupId": "BG000"
}
]
}
]
}
],
"paramType": "COUNT_OF_PARTICIPANTS",
"unitOfMeasure": "Participants"
},
{
"title": "Region of Enrollment",
"classes": [
{
"title": "United States",
"categories": [
{
"measurements": [
{
"value": "8",
"groupId": "BG000"
}
]
}
]
}
],
"paramType": "NUMBER",
"unitOfMeasure": "participants"
},
{
"title": "enrollment",
"classes": [
{
"categories": [
{
"measurements": [
{
"value": "8",
"groupId": "BG000"
}
]
}
]
}
],
"paramType": "COUNT_OF_PARTICIPANTS",
"unitOfMeasure": "Participants"
}
]
}
}
},
{
"op": "add",
"path": "/documentSection",
"value": {
"largeDocumentModule": {
"largeDocs": [
{
"date": "2015-05-12",
"size": 1679294,
"label": "Study Protocol and Statistical Analysis Plan",
"hasIcf": false,
"hasSap": true,
"filename": "Prot_SAP_000.pdf",
"typeAbbrev": "Prot_SAP",
"uploadDate": "2020-09-30T15:45",
"hasProtocol": true
}
]
}
}
}
]